 Boston MedTech Advisors assists medical technology companies and healthcare organizations advance their business by providing:
Boston MedTech Advisors provides practical business services to:
- Established and growing medical technology companies
- Healthcare providers
- Young organizations and entrepreneurs
- Private and institutional investors
April 2013
Boston MedTech Advisors (BMTA) congratulates Echosens on the receipt of FDA market clearance for its FibroScan® system. FibroScan® is the first medical device to be cleared as an aid to clinical management of patients with liver disease. BMTA is proud to have contributed to this pioneering effort by preparing and filing the submission and conducting the regulatory interactions with FDA throughout the review process.
|
PRINT PAGE
